Renalytix AI, the developer of the KidneyIntelX kidney disease prognosis platform, is partnering with the American Diabetes Association to improve early diagnosis and treatment of kidney disease in people with type 2 diabetes.
Renalytix is focused on “bioprognosis” of kidney health
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?